fr   en
Clinical Studies
Phase :    
Announcement :   
Select a Pharma :
Select a product :
Select a disease :
Choose date:
[<<]      «      47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57      »      [57]
Date Phase Anouncement Biotech Pharma Product Disease Country Other
2006-07-25 I Result Zymogenetics (USA) Serono (Switzerland)   Atacicept (soluble receptor which binds to TNF family cytokines, involved in B cell survival and the production of autoantibodies) systemic lupus erythaematosus   See details
2006-07-13 I Launch Karo Bio (Sweden)   KB 3305 Type 2 diabetes   See details
2006-06-30 I Result Karo Bio (Sweden)   KB2115 dyslipidaemia   See details
2006-06-29 I Launch Decode Genetics (Iceland)   DG051 (a leukotriene A4 hydrolase (LTA4H) inhibitor ) prevention of heart attacks   See details
2006-06-27 II Launch Astion Pharma (Denmark)   ASF-1075 (immunomodulator) Hand dermatitis four sites in Denmark and Germany. See details
2006-06-26 II Result Decode Genetics (Iceland) Cephalon (USA) CEP-1347 (molecule targeting a metabolic pathway involving the MAP3K9 kinase) asthma   See details
2006-06-22 II Launch Decode Genetics (Iceland)   DG041 (selective antagonist of the EP3 receptor for prostaglandins E2) peripheral arterial disease   See details
2006-06-12 II Launch Theravance (USA) GSK (UK) 642444 - Beta2 agonist asthma   See details
2006-06-08 II Launch Array BioPharma (USA) AstraZeneca (United Kingdom) AZD6244 (MEK1/2 inhibitor) malignant melanoma   See details
2006-06-07 III Launch Jerini (Germany)   icatibant (B2 bradykinin receptor antagonist) angioneurotic oedema ten European countries and Israel See details
2006-06-02 II Launch Innate Pharma (France)   IPH 1101 (bromohydrin pyrophosphate - a non-conventional gamma9delta2 lymphocyte agonist.) metastatic kidney cancer About fifteen of hospitals in three European countries See details
2006-05-23 Other Launch     HuMax-CD20 (ofatumumab - Arzerra®) B-cell chronic lymphocytic leukemia   See details
2006-05-17 III Launch Decode Genetics (Iceland)   DG031 (inhibitor of the 5-lipoxygenase activating protein, FLAP) prevention of heart attack   See details
2006-05-16 III Launch BioAlliance Pharma (France)   Loramyc® (miconazole Lauriad®) oropharyngeal candidosis USA See details
2006-04-10 III Launch Nuvelo (USA) Bayer Healthcare (Germany) alfimeprase Acute peripheral arterial occlusion international study See details
[<<]      «      47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57      »      [57]